热线电话: 021-34661275
产品分类/PRODUCT CLASSIFICATION

上海细胞库

人源细胞系| 稳转细胞系| 基因敲除株| 基因点突变细胞株| 基因过表达细胞株| 重组细胞系| 猪的细胞系| 马细胞系| 兔的细胞系| 犬的细胞系| 山羊的细胞系| 鱼的细胞系| 猴的细胞系| 仓鼠的细胞系| 狗的细胞系| 牛的细胞| 大鼠细胞系| 小鼠细胞系| 其他细胞系|

原代细胞

原代细胞| 永生化细胞|

细胞培养

血清| 无血清冻存| 细胞培养试剂盒| 普通培养基| 完全培养基| 细胞污染预防| 细胞污染清除| 细胞培养辅助试剂|

细胞服务

STR鉴定服务| ATCC代购服务|

酶联试剂盒

人ELISA试剂盒| 大鼠ELISA试剂盒| 小鼠ELISA试剂盒| 兔ELISA试剂盒| 猪ELISA试剂盒| 鱼ELISA试剂盒| 牛ELISA试剂盒| 犬ELISA试剂盒| 鸭ELISA试剂盒| 豚鼠ELISA试剂盒| 鸡ELISA试剂盒| 绵羊ELISA试剂盒| 山羊ELISA试剂盒| 仓鼠ELISA试剂盒| 植物ELISA试剂盒| 药残留类试剂盒| 其他ELISA试剂盒|

生化试剂盒

生化试剂盒| 微量法检测盒| 分光法检测盒| 胶体金检测盒|

PCR试剂盒

荧光探针PCR试剂盒| 染料荧光PCR试剂盒| 核酸扩增/纯化| 普通PCR检测试剂盒| 质粒菌种感受态|

抗体蛋白

蛋白多肽| 抗体| 免疫组化| 免疫球蛋白|

试剂耗材

标准试液| 科研试剂| 缓 冲 液| 实验耗材| 高效液相色谱对照品|

首页 > 抗体蛋白 > 抗体
PE anti-mouse CD3 Antibody
产品名称：
PE anti-mouse CD3 Antibody
产品类别：
抗体
产品编号：
100205
产品应用：
100205
[价格]
规格 价格 库存
50µg ￥ 732 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
γδTCR-positive T-T hybridoma D1
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 ?g per 106 cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Additional reported application (for relevant formats) include: spatial biology (IBEX)1,2.

Application References

(PubMed link indicates BioLegend citation)
  1. Radtke?AJ,?et al.?2020.?Proc Natl Acad Sci U S A.?117:33455-65. (SB)?PubMed
  2. Radtke?AJ,?et al.?2022.?Nat Protoc.?17:378-401. (SB)?PubMed
Product Citations
  1. Zuchtriegel G, et al. 2016. PLoS Biol. 14: 1002459. PubMed
  2. Xu C, et al. 2017. Biochemical and Biophysical Research Communications. 10.1016/j.bbrc.2017.05.071. PubMed
  3. Correa S, et al. 2020. ACS Nano. 2224:14. PubMed
  4. Gonalves S, et al. 2021. Cell Reports. 34(11):108860. PubMed
  5. Reboldi A, et al. 2016. Sci Transl Med. 352: aaf4822. PubMed
  6. Gazit R, et al. 2014. J Exp Med. 211:1315. PubMed
  7. Baryawno N et al. 2019. Cell. 177(7):1915-1932 . PubMed
  8. Shen S, et al. 2018. Pain Med. 19:686. PubMed
  9. Ushijima M, et al. 2018. Front Immunol. 9:243. PubMed
  10. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  11. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  12. Jong RM, et al. 2022. J Immunol. 208:407. PubMed
  13. Bedi B, et al. 2012. Proc Natl Acad Sci U S A. 109:275. PubMed
  14. Baptista AP et al. 2019. Immunity. 50(5):1188-1201 . PubMed
  15. Kunimura K, et al. 2020. Cell Reports. 29(9):2823-2834.e7.. PubMed
  16. Xu ZH, et al. 2021. Mediators Inflamm. 2021:8856326. PubMed
  17. Liang W, et al. 2020. Nat Commun. 4.563888889. PubMed
  18. Lutzmann M, et al. 2019. Cell Rep. 28:2851. PubMed
  19. Periasamy S, et al. 2017. Nat Commun. 8:15564. PubMed
  20. Lechner AJ et al. 2017. Cell stem cell. 21(1):120-134 . PubMed
  21. Shu T, et al. 2022. Eur Respir J. Online ahead of print. PubMed
  22. Al-Rifai R, et al. 2022. Nat Commun. 13:6592. PubMed
  23. Jazowiecka-Rakus J, et al. 2021. Cancers (Basel). 13:. PubMed
  24. Schmidt D, et al. 2016. PLoS One. 11: 0159059. PubMed
  25. He C, et al. 2020. Clin Transl Med. 10:e39. PubMed
  26. Ma C, et al. 2018. Science. 360:eaan5931. PubMed
  27. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  28. Kuang Z, et al. 2020. Antib Ther. 3:227. PubMed
  29. Hu D, et al. 2021. J Cell Mol Med. 25:2900. PubMed
  30. Mathur S, et al. 2021. JCI Insight. 6:. PubMed
  31. Ohyagi M, et al. 2021. Nat Commun. 12:7344. PubMed
  32. Yan X, et al. 2022. Int J Biol Sci. 18:585. PubMed
  33. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  34. Tu X, et al. 2022. Nat Commun. 13:6977. PubMed
  35. Vannini N, et al. 2019. Cell Stem Cell. 24:405. PubMed
  36. Biram A, et al. 2020. Cell Rep. 30:1910. PubMed
  37. Delgado‐Benito V et al. 2018. Molecular cell. 72(4):636-649 . PubMed
  38. Mariani SA, et al. 2019. Immunity. 50:1439. PubMed
  39. Stutchfield B, et al. 2015. Gastroenterology. 149: 1896-1909.e14. PubMed
  40. Koren N, et al. 2021. Cell Host Microbe. 29(2):197-209.e5. PubMed
  41. Stivala S, et al. 2019. J Clin Invest. 130:1596. PubMed
  42. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  43. Wang F, et al. 2021. Cell Mol Gastroenterol Hepatol. 13:257. PubMed
  44. Zhou Y, et al. 2022. Nat Commun. 13:2906. PubMed
  45. Domingos-Pereira S, et al. 2019. Cancer Immunol Res. 7:621. PubMed
  46. Lin H, et al. 2019. Infect Immun. 87:e00055-19. PubMed
  47. Pedraza–Zamora CP, et al. 2017. Parasite Immunol. 39:4. PubMed
  48. McAlpine CS, et al. 2021. Nature. 595:701. PubMed
  49. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  50. Goldman E, et al. 2021. Cells. 10:. PubMed
  51. Cassidy BR, et al. 2020. J Neuroinflammation. 17:259. PubMed
  52. Wu J, et al. 2020. Immunity. 53:115. PubMed
  53. Chen Y, et al. 2015. PLoS One. 10: 0135217. PubMed
  54. Li Y, et al. 2020. Cell Stem Cell. 27(5):732-747.e7. PubMed
  55. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  56. Doonan J, et al. 2019. Nat Commun. 10:1554. PubMed
  57. Halpern KB, et al. 2018. Nat Biotechnol. 36:962. PubMed
  58. Deng M, et al. 2020. Nat Commun. 11:2193. PubMed
  59. Paul S, et al. 2018. Appl Microbiol Biotechnol. 102:8895. PubMed
  60. Marinescu CI, et al. 2021. Stem Cell Res Ther. 12:319. PubMed
  61. Shi R, et al. 2022. Theranostics. 12:875. PubMed
  62. Cheng B, et al. 2022. Cancer Commun (Lond). 42:17. PubMed
  63. Glaros V, et al. 2021. Immunity. 54:2005. PubMed
  64. Hu J, et al. 2022. J Neuroinflammation. 19:71. PubMed
  65. O'Connor T, et al. 2020. Cancer Cell. 36(3):250-267. PubMed
  66. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  67. Chauveau A, et al. 2020. Immunity. 52:794. PubMed
  68. Mishra BB, et al. 2017. Nat Microbiol. 2:17072. PubMed
  69. Kim JH, et al. 2019. Mol Med. 25:33. PubMed
  70. Pedraza-Zamora C, et al. 2017. Parasite Immunol. 10.1111/pim.12420. PubMed
  71. Fang E, et al. 2022. MedComm (2020). 3:e117. PubMed
  72. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  73. Zuo S, et al. 2021. J Immunother Cancer. 9:. PubMed
  74. Lewandowski JP, et al. 2020. Genome Biol. 1.039583333. PubMed
  75. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  76. Xiang W, et al. 2018. Nat Commun. 9:2574. PubMed
  77. Huang Z, et al. 2021. Nat Commun. 12:145. PubMed
  78. Cho K, et al. 2021. iScience. 24:103117. PubMed
  79. Zhou Z, et al. 2022. Infect Immun. 90:e0045321. PubMed
  80. Bullard BL, et al. 2022. NPJ Vaccines. 7:65. PubMed
  81. Tomala J, et al. 2020. Methods Mol Biol. 2111:101. PubMed
  82. Nikolos F, et al. 2022. Nat Commun. 13:1487. PubMed
  83. Rozanski C, et al. 2015. J Immunol. 194:4717. PubMed
  84. Zou D, et al. 2020. EBioMedicine. 52:102652. PubMed
  85. Sanmarco LM, et al. 2021. Nature. 590:473. PubMed
  86. Fang H, et al. 2020. Nat Commun. 4.661805556. PubMed
  87. Tummers B, et al. 2020. Immunity. 52(6):994-1006.e8. PubMed
  88. Sun J et al. 2018. Cell stem cell. 23(3):355-369 . PubMed
  89. Huang L, et al. 2018. Exp Neurol. 300:41. PubMed
  90. Ding Y, et al. 2020. Evid Based Complement Alternat Med. 2020:9521073. PubMed
  91. Zhang T, et al. 2020. Cell. 180(6):1115-1129. PubMed
  92. Gamrekelashvili J, et al. 2021. Bio Protoc. 11:e4007. PubMed
  93. Feng Y, et al. 2022. J Nanobiotechnology. 20:193. PubMed
  94. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  95. Cai Z, et al. 2020. Cell Rep. 31:107816. PubMed
  96. Yamamura K, et al. 2017. Nat Commun. 8:13946. PubMed
  97. Hsieh Y, et al. 2014. Infect Immun . 82:2087. PubMed
  98. Winchell CG, et al. 2020. Front Immunol. 1.077083333. PubMed
  99. Chan WY, et al. 2019. Infect Immun. 87:. PubMed
  100. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  101. Olson B, et al. 2021. Brain Behav Immun. 97:102. PubMed
  102. Schneider A, et al. 2014. J Leukoc Biol. 96:857. PubMed
  103. Yao C, et al. 2018. Autophagy. 1.854861111. PubMed
  104. Zhang MS, et al. 2022. Nat Commun. 13:954. PubMed
  105. Jazowiecka-Rakus J, et al. 2020. Mol Ther Oncolytics. 18:335. PubMed
  106. Chen H, et al. 2022. Front Pharmacol. 13:827520. PubMed
  107. Zhou T, et al. 2021. Bioact Mater. 0.734027778. PubMed
  108. Kim MY, et al. 2022. Nat Commun. 13:3296. PubMed
  109. Zhou H, et al. 2021. Cell Death Discov. 7:332. PubMed
  110. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  111. Lu C, et al. 2020. Cancer Cell. 39(1):96-108.e6. PubMed
  112. Ulu?kan ?, et al. 2020. Cell Reports. 29(4):844-859.e3.. PubMed
  113. Rodríguez L, et al. 2021. Biomolecules. 11: . PubMed
  114. Maulhardt HA, et al. 2020. Invest New Drugs. 1618:38. PubMed
  115. Yu H, et al. 2015. PLoS One. 10: 0143001. PubMed
  116. Fathman J, et al. 2010. Proc Natl Acad Sci U S A. 107:3663. PubMed
  117. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  118. Gundra UM, et al. 2017. Nat Immunol. 1.195833333. PubMed
  119. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  120. Vannini N, et al. 2016. Nat Commun. 7:13125. PubMed
  121. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  122. Crowe J, et al. 2020. PLoS Pathog. 16:e1008391. PubMed
  123. Das A, et al. 2020. J Bone Miner Res. 36:199. PubMed
  124. Gawish R, et al. 2022. Elife. 11:. PubMed
  125. Zeng F, et al. 2021. J Invest Dermatol. 596:141. PubMed
  126. Guo S, et al. 2021. Frontiers in Immunology. 11:614667. PubMed
  127. Xiang W, et al. 2020. Signal Transduct Target Ther. 0.374305556. PubMed
  128. Hayashi K, et al. 2020. Nat Commun. 4.832638889. PubMed
  129. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  130. Zuo S, et al. 2021. EBioMedicine. 64:103240. PubMed
RRID
AB_312662 (BioLegend Cat. No. 100205) AB_312663 (BioLegend Cat. No. 100206)

Antigen Details

Structure
Ig superfamily, CD3/TCR, 20 kD
Distribution

Thymocytes (differentiation dependent), mature T cells, NK-T cells

Function
Antigen recognition, TCR signal transduction, T cell activation
Ligand/Receptor
Peptide antigen/MHC-complex
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Davis MM. 1990. Annu. Rev. Biochem. 59:475.
3. Weiss A, et al. 1994. Cell 76:263.

Gene ID
12502 View all products for this Gene ID
UniProt
View information about CD3 on UniProt.org

联系我们

TEL：021-34661275 　点击拨打热线